News and Trends 4 Jul 2017
British Liquid Biopsy for Ovarian Cancer Outperforms the Gold Standard
The British company Angle has announced results from a large-scale trial that seem to indicate its liquid biopsy technology could surpass the gold standard in ovarian cancer diagnosis. Angle, in the UK, is developing liquid biopsy tests to replace biopsies in the diagnosis of cancer. The company has announced results from a 400-patient trial in […]